case report aspiration during anesthesia glp-1 receptor agonist 2023 Perioperative Management of Agonists: Balancing Risk with Therapeutic Benefit | SN Comprehensive Clinical Medicine Glucagon-like peptide-1 receptor agonists before
Description
2024;403(10434):e21e31
The FDA is currently evaluating whether GLP-1 medications may increase the risk of suicidal thoughts or actions
At the same time, new therapeutic approaches are emerging
Moreover, drugs with greater efficacy are being developed by combining two or three of GLP-1 and GIP or glucagon or amylin
doi: 10.1038/s41467-020-18751-8
These benefits are independent of baseline glycemia and duration of diabetes and only minimally related to their glucose-lowering efficacy (254)
